TD Cowen is Bullish on BrightSpring Health Services, Inc. (BTSG)

TD Cowen has reiterated its bullish stance on BrightSpring Health Services, Inc. (BTSG), upgrading its price objective to $46 and maintaining a Buy rating, citing strong specialty generics trends. Other firms, including BMO Capital and BTIG, have also increased their price targets for BTSG, highlighting the company’s competitive advantage, pharmaceutical ties, and consistent operational performance. The stock’s recent performance is largely attributed to accelerated growth within its specialty division.